Document is current
Any future updates will be listed below
-
Authors
Buchholtz, N. V. E. J.
Nühn, M. M.
de Jong, T. C. M.
Stienstra, T. A. T.
Reddy, K.
Ndung’u, T.
Ndhlovu, Z. M.
Fisher, K.
Palmer, S.
Wensing, A. M. J.
Symons, J.
Nijhuis, M.
-
Funding
Funding for this research was provided by:
AIDSfonds (LSHM19100-SGF)
Health Holland (LSHM20012-SGF)
Aidsfonds/ZonMw (446002508)
Bill and Melinda Gates Foundation (OPP1212883)
Delaney AIDS Research Enterprise (1UM1AI126611-01 802)
Australian National Health and Medical Research Council (APP1149990)
- License Information
-
More Information
Article History
Received: 14 November 2023
Accepted: 22 January 2024
First Online: 31 January 2024
Declarations
:
: All participants provided written consent. The studies from which the HIV-1 subtype B sequences originate have been reviewed by institutional review boards at UCSF, the Western Sydney Local Health District, which includes the West-Mead institute for Medical Research, the Research Ethics Committees at the Alfred and Avenue Hospitals in Melbourne, and the University of Melbourne Ethics Committee [CitationRef removed–CitationRef removed]. The subtype C sequence studies were approved by the Biomedical Research Ethics Committee of the University of KwaZulu-Natal and the institutional Review Board of Massachusetts General Hospital [CitationRef removed, CitationRef removed].
: Not applicable.
: The authors declare no conflict of interest.
